# Resolving Bile Reflux by Lanreotide in Patients With Roux-en-Y Gastrojejunostomy

> **NCT02054637** · PHASE2 · UNKNOWN · sponsor: **Universitair Ziekenhuis Brussel** · enrollment: 10 (estimated)

## Conditions studied

- Acid Reflux Esophagitis
- Non-acid Reflux Esophagitis

## Interventions

- **DRUG:** Lanreotide

## Key facts

- **NCT ID:** NCT02054637
- **Lead sponsor:** Universitair Ziekenhuis Brussel
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-04
- **Primary completion:** 2015-12
- **Final completion:** 2016-04
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2014-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02054637

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02054637, "Resolving Bile Reflux by Lanreotide in Patients With Roux-en-Y Gastrojejunostomy". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02054637. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*